The Food and Drug Administration is releasing additional doses of Moderna’s omicron-specific COVID-19 boosters that were previously withheld from the government’s initial rollout earlier this month while the agency conducted safety inspections at an Indiana packaging plant.

Recommended Stories

No COVID-19 booster shot needed ‘at this time,’ FDA and CDC say

CDC advisory group votes to add COVID-19 shot to child vaccination schedule

Moderna asks FDA to authorize fourth dose of COVID vaccine for adults